Aditxt subsidiary Pearsanta engages Spartan Capital for planned IPO
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/2/2026
- Wall Street futures fall as oil, Treasury yields rise on Iran tensions
- Oil prices fall after hitting over one-month high; traders weigh supply risks
- Dell again lifts annual forecasts as AI demand powers record results
- Uber stock gains 2% as tech giant cuts 3,300 jobs in major restructuring
- Berkshire’s Abel says data centers are energy opportunity
- GoPro to merge with Starman Optical in $285M recapitalization deal
- GoPro (GPRO) Halted, News Pending
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- Gap taps Coach architect Reed Krakoff for $29.95-$498 handbag line
- S&P Global shares rise on report of possible CapIQ spinoff
Aditxt’s Subsidiary, Pearsanta, Inc. Engages Spartan Capital as Lead Underwriter for its Planned IPO Intending to Drive Clinical Validation and Commercial Rollout of Its Mitomic™ Platform Technolo
July 29, 2025 9:00 AM EDTPlanned IPO Aligns with Aditxts Acquire, Build and Capitalize (ABC) Monetization Framework
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)-- Aditxt, Inc. (Nasdaq: ADTX) ("Aditxt" or the "Company"), a social innovation platform dedicated to accelerating promising health innovations, today announced that its subsidiary, Pearsanta, Inc., (Pearsanta) has engaged Spartan Capital Securities, LLC (Spartan) as lead underwriter for its planned Initial Public Offering (IPO). This marks an important milestone in Aditxts Acquire, Build, and Capitalize (ABC) strategy, which is designed to accelerate the growth of innovative health companies.
Spartan will serve as Pearsantas exclusive... More
